Market Cap 7.88M
Revenue (ttm) 43.79M
Net Income (ttm) -37.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -85.36%
Debt to Equity Ratio -1.46
Volume 127,002
Avg Vol 65,321
Day's Range N/A - N/A
Shares Out 675,000.00
Stochastic %K 18%
Beta N/A
Analysts Strong Buy
Price Target $15.00

Company Profile

Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxopl...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 276 9800
Address:
IDA Business Park, Bray, Ireland
Zephix
Zephix Aug. 18 at 7:08 PM
$TRIB looking good
0 · Reply
deepthinker
deepthinker Aug. 18 at 5:13 PM
$TRIB Still don’t know about MVPHS. Assuming they’re over now, I would expect that they’d be granted an extension if necessary. But, you never know.
0 · Reply
deepthinker
deepthinker Aug. 18 at 3:14 PM
$TRIB So, I think the way this goes is that Trinity has a starting fluid, pretty standard formulation. The selling point is that they can make small customizations and guarantee purity, lot tracing, etc. Since they’re nearby, this can be done quickly. Then, they’ll deliver it, monitor it, change it when necessary, recycle it. As this goes on, the two companies will be experimenting with fluid modification and Trinity will presumably be building an on-site monitoring device. What will change over time is that temperatures will rise, and cooling will take place at ever lower temperatures. So, Trinity will serve as Echelon’s experimental lab/research team. The goal would be to slowly expand to other regions.
1 · Reply
jeandaniel13
jeandaniel13 Aug. 18 at 3:00 PM
$TRIB 14 end of day
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 9:25 PM
0 · Reply
deepthinker
deepthinker Aug. 17 at 7:49 PM
$TRIB Ok, so we’re waiting on MVPHS.
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:35 PM
1 · Reply
jeandaniel13
jeandaniel13 Aug. 17 at 3:15 PM
$TRIB going to 25 soon
1 · Reply
deepthinker
deepthinker Aug. 17 at 1:56 PM
$TRIB Don’t know how many public shares , so don’t about MVPHS compliance.
1 · Reply
deepthinker
deepthinker Aug. 17 at 1:27 PM
$TRIB Whoever thought that health care and data centers could be merged in this way is a genius.
1 · Reply
Latest News on TRIB
Trinity Biotech trading halted, news pending

2026-07-23T23:50:13.000Z - 25 days ago

Trinity Biotech trading halted, news pending


Trinity Biotech announces plan to implement ADS ratio change

2026-07-22T11:35:25.000Z - 27 days ago

Trinity Biotech announces plan to implement ADS ratio change


Trinity Biotech Earnings release: Q1 2026

Jun 18, 2026, 4:00 PM EDT - 2 months ago

Trinity Biotech Earnings release: Q1 2026


Trinity Biotech Slides: Q1 2026

Jun 18, 2026, 4:00 PM EDT - 2 months ago

Trinity Biotech Slides: Q1 2026


Trinity Biotech Registration statement: Registration filing

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 3 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 3 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Trinity Biotech Annual report: Q4 2025


Trinity Biotech Slides: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Trinity Biotech Slides: Q4 2025


Trinity Biotech Provides Business and Trading Update

Mar 10, 2026, 7:45 AM EDT - 5 months ago

Trinity Biotech Provides Business and Trading Update


Trinity Biotech secures $25M standby equity purchase agreement

2026-02-25T14:14:32.000Z - 6 months ago

Trinity Biotech secures $25M standby equity purchase agreement


Trinity Biotech Registration statement: Registration filing

Feb 25, 2026, 7:00 AM EST - 6 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech receives noncompliance notification from Nasdaq

2026-02-20T22:10:49.000Z - 6 months ago

Trinity Biotech receives noncompliance notification from Nasdaq


Trinity Biotech receives noncompliance notification from Nasdaq

2026-02-13T22:10:18.000Z - 6 months ago

Trinity Biotech receives noncompliance notification from Nasdaq


Trinity Biotech files to sell 55.89M American depositary shares

2026-01-15T21:35:23.000Z - 7 months ago

Trinity Biotech files to sell 55.89M American depositary shares


Trinity Biotech Slides: Q3 2025

Dec 23, 2025, 9:30 AM EST - 8 months ago

Trinity Biotech Slides: Q3 2025


Trinity Biotech Slides: Q2 2025

Dec 23, 2025, 8:30 AM EST - 8 months ago

Trinity Biotech Slides: Q2 2025


Trinity Biotech Slides: Q1 2025

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Trinity Biotech Slides: Q1 2025


Trinity Biotech Earnings release: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Earnings release: Q4 2024


Trinity Biotech Annual report: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Annual report: Q4 2024


Trinity Biotech Registration statement: Registration Filing

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech Registration statement: Registration Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech Earnings Call Transcript: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings Call Transcript: Q3 2024


Trinity Biotech Earnings release: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings release: Q3 2024


Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Announces Q3 2024 Financial Results


Trinity Biotech Registration statement: Registration Filing

Nov 15, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech to Announce Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 1 year ago

Trinity Biotech to Announce Q3 2024 Financial Results


Zephix
Zephix Aug. 18 at 7:08 PM
$TRIB looking good
0 · Reply
deepthinker
deepthinker Aug. 18 at 5:13 PM
$TRIB Still don’t know about MVPHS. Assuming they’re over now, I would expect that they’d be granted an extension if necessary. But, you never know.
0 · Reply
deepthinker
deepthinker Aug. 18 at 3:14 PM
$TRIB So, I think the way this goes is that Trinity has a starting fluid, pretty standard formulation. The selling point is that they can make small customizations and guarantee purity, lot tracing, etc. Since they’re nearby, this can be done quickly. Then, they’ll deliver it, monitor it, change it when necessary, recycle it. As this goes on, the two companies will be experimenting with fluid modification and Trinity will presumably be building an on-site monitoring device. What will change over time is that temperatures will rise, and cooling will take place at ever lower temperatures. So, Trinity will serve as Echelon’s experimental lab/research team. The goal would be to slowly expand to other regions.
1 · Reply
jeandaniel13
jeandaniel13 Aug. 18 at 3:00 PM
$TRIB 14 end of day
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 9:25 PM
0 · Reply
deepthinker
deepthinker Aug. 17 at 7:49 PM
$TRIB Ok, so we’re waiting on MVPHS.
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:35 PM
1 · Reply
jeandaniel13
jeandaniel13 Aug. 17 at 3:15 PM
$TRIB going to 25 soon
1 · Reply
deepthinker
deepthinker Aug. 17 at 1:56 PM
$TRIB Don’t know how many public shares , so don’t about MVPHS compliance.
1 · Reply
deepthinker
deepthinker Aug. 17 at 1:27 PM
$TRIB Whoever thought that health care and data centers could be merged in this way is a genius.
1 · Reply
deepthinker
deepthinker Aug. 17 at 1:13 PM
$TRIB Would not be surprised to see Trinovium spun-off at some point, maybe with Echelon and/or Brookfield taking stakes.
1 · Reply
STACKD0E
STACKD0E Aug. 17 at 12:52 PM
0 · Reply
deepthinker
deepthinker Aug. 17 at 12:44 PM
$TRIB I’m going to say that Trinovium is effectively the “clean” cooling research division of Echelon (dielectric fluids may have environmental concerns).
1 · Reply
focafoca99
focafoca99 Aug. 17 at 12:43 PM
$TRIB initiated a collaboration between Trinovium and Echelon Data Centres to develop liquid cooling for AI.
0 · Reply
m1ster_leboeuf
m1ster_leboeuf Aug. 12 at 12:14 PM
0 · Reply
Think_Bigly
Think_Bigly Aug. 6 at 8:48 PM
$TRIB 'The hyperscalers at the top are distributing capex across seven distinct physical layers which means the picks and shovels opportunity set has expanded well beyond Nvidia into cooling, grid infrastructure, and power generation.'
0 · Reply
johnnylawrencecobra
johnnylawrencecobra Jul. 31 at 8:06 PM
0 · Reply
johnnylawrencecobra
johnnylawrencecobra Jul. 31 at 11:02 AM
0 · Reply
Think_Bigly
Think_Bigly Jul. 30 at 5:41 PM
$DFNS $TRIB 675k O/S - Now EBITDA+ -Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market -Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests -New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem https://trinitybiotech.com/press-releases-news-insights/
0 · Reply
deepthinker
deepthinker Jul. 30 at 3:32 PM
$TRIB Perceptive effectively owns this company. Trinity’s main purpose is to advance the CGM, because that’s what Perceptive wants done. Perceptive does not care about squeezing out a few extra bucks. They want big wins. Perceptive has been babysitting this CGM for 7+ years now. They want to get this thing across the finish line, finally.
1 · Reply